• Explore /
  • Poster
  • / Effect of type of antibiotics (Abx) on outcomes with immune checkpoint inhibitors (ICIs) in patients (pts) with metastatic urothelial carcinoma (mUC) in a real-world setting.

Effect of type of antibiotics (Abx) on outcomes with immune checkpoint inhibitors (ICIs) in patients (pts) with metastatic urothelial carcinoma (mUC) in a real-world setting.

Abstract Poster

Authors

Charbel Hobeika

Charbel Hobeika

Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH

Charbel Hobeika , Scott Dawsey , Ubenthira Patgunarajah , David Lynn , Nikhil Pramod , Wei Wei , Monica Nair , Kimberly Maroli , Allison Martin , Moshe Chaim Ornstein , Christopher Eing Wee , Timothy D. Gilligan , Amanda Nizam , Amanda Bonham , Omar Y. Mian , Paul G. Pavicic Jr., C. Marcela Diaz-Montero , Shilpa Gupta

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Urothelial Carcinoma

Track

Urothelial Carcinoma

Sub Track

Therapeutics

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 640)

DOI

10.1200/JCO.2024.42.4_suppl.640

Abstract #

640

Poster Bd #

J4

Abstract Disclosures

Similar Posters

First Author: Ubenthira Patgunarajah

First Author: Shilpa Gupta

First Author: David Lynn

Poster

2021 ASCO Annual Meeting

Real-world treatment patterns and clinical outcomes among patients with metastatic urothelial carcinoma.

Real-world treatment patterns and clinical outcomes among patients with metastatic urothelial carcinoma.

First Author: Daniel M. Geynisman